Identification of leptospiral 3-hydroxyacyl-CoA dehydrogenase released in the urine of infected hamsters
© Segawa et al.; licensee BioMed Central Ltd. 2014
Received: 26 December 2013
Accepted: 7 May 2014
Published: 21 May 2014
Leptospirosis is a global zoonosis caused by pathogenic Leptospira. The non-specific clinical signs and symptoms of leptospirosis lead to its misdiagnosis. To date, there is still no reliable rapid test kit that can accurately diagnose leptospirosis at bedside or in field. In this research, with the ultimate goal of formulating a rapid and accurate diagnostic tool for leptospirosis, we aimed to identify leptospiral proteins excreted in urine of infected hamsters, which are thought to mimic Weil’s disease.
Hamsters were subcutaneously infected with leptospires, and the general attributes of urine as well as the proteins excreted in it were examined. Some leptospiral proteins were found to be excreted in the urine from the early phase of infection. The most important finding of this study was the detection of the lipid-metabolizing enzyme, 3-hydroxyacyl-CoA dehydrogenase (HADH), before the onset of illness, when leptospires were not yet detected in the urine of infected hamsters.
This is the first report on the detection of leptospiral HADH in the host urine, which may be a possible candidate leptospiral antigen that can be used in the early diagnosis of human and animal leptospirosis.
KeywordsLeptospirosis 3-hydroxyacyl-CoA dehydrogenase Urine Hamster Diagnosis
Leptospirosis is a global zoonosis caused by the pathogenic Leptospira spp. Outbreaks of leptospirosis usually occur after heavy rains followed by floods in tropical and subtropical developing countries, and recreational activities in developed countries [1, 2]. The genus Leptospira is comprised of 21 species and more than 300 serovars. Animals may become maintenance hosts of some serovars or incidental hosts of others . Infection of accidental hosts may cause severe or fatal disease. Wild rats, dogs, buffaloes, horses, and pigs are known to contract the disease and the surviving animals maintain the organisms in their kidneys. Infected animal urine contains leptospires, which may contaminate the environment once excreted, becoming a new source of infection for humans and susceptible animals. Infection of humans or animals occurs when leptospires penetrate both normal and injured skin and mucosal surfaces after direct contact with the urine of infected animals or indirectly from contaminated environments [1, 4].
Signs and symptoms of human leptospirosis are usually mild, however, 5% of cases develop the severe form presenting jaundice, renal failure, and pulmonary hemorrhage [1, 2, 4–6]. This zoonotic infection is treatable but its early phase has clinical presentations similar to many other diseases thereby complicating its clinical diagnosis. Early diagnosis of leptospirosis is essential to prevent progression to the severe stage because antibiotic treatment is effective when it is initiated early in the course of the disease.
The gold standards for diagnosis of leptospirosis are isolation of Leptospira by culture from blood, urine or tissues of infected hosts and the microscopic agglutination test (MAT) to detect antibody. However, results of these diagnostic methods can only be evaluated more than 10 days after the onset of illness. Furthermore, technical expertise is needed in order to perform the culture and MAT. In attempts to replace these two methods, other diagnostic methods were developed such as enzyme-linked immunosorbent assay (ELISA) , polymerase chain reaction (PCR) [8–11], and so on [12–16]. However, these are not simple or rapid tests that can be used at bedside [1, 2, 4, 17] and sophisticated equipment is needed in order to perform PCR. In addition, with the exception of PCR, the sensitivities of the other assays are not satisfactory, especially during the acute phase of infection . At present there is a lack of available kits that are able to detect leptospiral antigens in patient samples such as urine. Furthermore, there is also a need for simple and rapid leptospirosis diagnostic kits that are cheap, highly sensitive, highly specific, and can easily be used at bedside or in the field.
Urine is expected to be the best sample for diagnosis, because the urine of leptospirosis patients contains leptospiral antigens and can be collected easily [19–26]. Urine of patients has often been used for culture of Leptospira, however, more information on proteins can be obtained from urine .
The golden Syrian hamster is susceptible to Leptospira infection, and acute leptospirosis in the hamster model reproduces the severe form of human leptospirosis, and is therefore useful in evaluating diagnostic methods . In this study, we analyzed the characteristics and protein components of Leptospira-infected hamster urine in order to identify proteins that may be possibly used in developing rapid and accurate leptospiral antigen diagnostic kits. We identified a leptospiral protein, 3-hydroxyacyl-CoA dehydrogenase (HADH), which was found to be excreted in the urine of hamsters during the early phase of infection.
Changes in urine characteristics of hamsters during Leptospira infection
Changes in hamster urinary proteins during leptospiral infection
For detecting leptospiral proteins in hamster urine, we performed immunoblotting with rabbit polyclonal antibody against L. interrogans serovar Manilae. Three bands with sizes of 65, 52, and 30 kDa were detected in the post-infection urine (Figure 2B). These bands were already detected during the early phase of post-infection. During this phase, the hamster appeared healthy and no viable leptospires were recovered from the urine. 26 kDa protein was detected in urine before and during infection so this protein was not a result of infection.
Comparative analysis of urinary protein composition before and after Leptospira infection by using two dimensional electrophoresis (2-DE) and immunoblotting
Proteins with increased levels after Leptospira infection
List of hamster proteins excreted in urine that had increased levels of expression during infection
Urinary marker of diseases (Reference)
ceruloplasmin isoform b [Mus musculus]
alpha-1-inhibitor III [Rattus norvegicus]
30, 32, 33, 38
albumin [Microtus fortis fortis]
transferrin [Mus musculus]
Glomerular disease 
pregnancy protein 60 kDa
angiotensinogen [Rattus norvegicus]
Chronic kidney disease 
vitamin D-binding protein [Mus musculus]
AMBP protein precursor
Apolipoprotein A-I precursor
Glomerular disease 
46, 51, 52
pancreatic trypsin 1 [Rattus norvegicus]
protease, serine, 1 [Mus musculus]
50, 53, 54
transthyretin [Rattus norvegicus]
Cu/Zn superoxide dismutase
Endemic nephropathy 
List of leptospiral proteins excreted in hamster urine during Leptospira infection
conserved hypothetical protein
ABC transporter, atp-binding protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
conserved hypothetical protein
Identification of HADH in hamster urine
Detection of HADH in infected hamster urine with antiserum
We confirmed, by immunoblotting, that several leptospiral proteins were shed in the urine of infected hamsters from the early phase of infection (Figure 2B). On the 7-8th day post-infection, the amount of 52 and 65 kDa leptospiral antigens increased. It was suggested that the proportion of 30 kDa proteins decreased because of rich albumin passing into the urine. Furthermore, we performed 2-DE for a detailed examination of protein components. Patterns of urinary proteins were different between pre-infection and after the seventh day of infection. As mentioned earlier, the infected hamster urine consisted mostly of albumin, consequently we determined proteins that had increased expression. In 2-DE-immunoblotting, 60 kDa proteins were detected by anti-L. interrogans pAb (Figure 3D). However, though proteins with 52 and 30 kDa molecular weights were detected in SDS-PAGE-immunoblotting (Figure 2B), they were not found by 2-DE-immunoblotting (Figure 3D). This may be because the two proteins were diluted in 2-DE gel during pI separation or had specific pI outside 4–7. From the amino acid sequence, molecular weight of HADH is 52 kDa and this supports the probability that the 52 kDa band in immunoblotting of urine (Figure 2B), recombinant HADH study (Figure 4), and dilution experiments of urine (Figure 5) is leptospiral HADH. However in 2-DE-immunoblotting analysis, anti-L. interrogans pAb detected around 60 kDa protein which is revealed as leptospiral HADH by LC/MS/MS. Molecular weight shift like this (from 52 to 60 kDa) is sometimes observed in these kinds of experiments, and HADH was included in 60 kDa proteins in the 2-DE- immunoblotting (Figure 3D).
The most significant finding in our study was the detection in infected hamster urine of leptospiral protein LIC13300, which is 3-hydroxyacyl-CoA dehydrogenase (HADH) and is one of the intracellular enzyme proteins. This protein is classified as an oxidoreductase in fatty acid metabolic processes. It specifically catalyzes the third step of beta oxidation. Long-chain fatty acids are utilized by Leptospira as the sole carbon source and are metabolized by beta-oxidation. Therefore, a large amount of HADH may be produced intracellularly and released to get carbons and energy by oxidizing free fatty acid.
We produced rabbit antiserum against recombinant leptospiral HADH to detect the protein in infected hamster urine. The advantage of using anti-HADH pAb compared to the anti-pathogenic leptospires pAb is that the former is more specific than the latter. Using this antiserum, the protein (52 kDa) was successfully detected in urine after infection (Figure 5A), and an increase in band thickness at 7–8 days post infection was confirmed by serial dilution (Figure 5B). It seems that the appearance of 65 kDa protein in immunoblotting (Figure 5A) was due to non-specific reactions because normal hamster urine had the 65 kDa protein (Figure 5A) and normal rabbit serum also reacted with such protein (data not shown). During 0–6 days after infection, urine still appeared normal and leptospires were not shed in urine. Further study is needed to identify these proteins.
Hamsters and humans also have enzymes similar to leptospiral HADH. The amino acid sequences of this protein are conserved among Leptospira spp., however, the amino acid homology between hamster or human and L. interrogans serovar Copenhageni were only 25.08% or 32.44%, respectively. It is, therefore, expected that the antisera against leptospiral HADH cannot recognize the protein of hamsters.
Several studies previously reported that the abundant proteins or LPS on the surface of outer membrane were suitable as targets for vaccine and diagnosis of leptospirosis such as outer membrane proteins [38, 39], LIC11207 , OmpL1 [41, 42], MPL17 and MPL21 , HbpA , LigA , LP29 and LP49 , LipL32 [47–50], LipL21 [50, 51], LipL41 , flagellin protein . Moreover, it was also reported that different proteins were expressed in leptospires shed in chronically infected rats compared to leptospires cultured in vitro, and that the leptospires in rat urine affected urinary protein composition . However, we were not able to identify any of the previously reported leptospiral proteins in the urine either by immunoblotting with anti-L. interrogans pAb or MS/MS analysis. The polyclonal antibodies were produced in rabbits, and we confirmed that proteins were recognized by this antibody using immunoblotting and MS/MS analyses. The antibody could recognize some membrane proteins such as LipL32 and LipL41 when bacterial cells were used for immunoblotting (unpublished data). However, leptospiral membrane lipoproteins were not detected in the urine, probably due to their low concentration. These results suggest that not only membrane proteins but also intracellular proteins, such as HADH, can be used as candidates for leptospirosis diagnosis.
We investigated the changes in the attributes of hamster urine prior to infection and a day just before death in a hamster model, and found that the conditions drastically changed one day prior to death. The pH of hamster urine is usually about 8, and it was found to have become acidic before death (Figure 1B). Urinary test results suggest that this acidification was caused by renal failure, like nephritis. Hamster urine is usually cloudy due to a high concentration of calcium carbonate . But, it became clear on the day prior to death due to leptospirosis. Calcium carbonate is deposited in alkali conditions, and dissolved in acidic conditions. Leptospira- infected hamster urine was about pH 6, and the urine remained clear even in alkaline condition induced by adding sodium hydroxide. It means that the amount of calcium carbonate excreted in urine decreased just before the hamsters succumbed to infection. After the seventh day of infection, viable leptospires could be recovered from the urine. Thus, it is suggested that leptospires are not shed from the kidneys until just before death.
Most of the urinary proteins detected in this study were associated with host renal failure such as acute renal transplant rejection [29, 30], glomerular disease [31, 32, 36], diabetes mellitus type 2 [33, 35], chronic kidney disease , pancreatitis , and endemic nephropathy . The proteins identified in our study, except for leptospiral HADH, are biomarkers known to be involved in renal failure, but are not specific for Leptospira infection. Albumin was the main protein detected in infected hamster urine during the end stage of infection (Figure 2). This is one of the plasma proteins and its primary function is to maintain the colloidal osmotic pressure in both the vascular and extra-vascular spaces. The urine-excreted proteins can serve as markers for glomerular disease [31, 32] and diabetes .
HADH was detected in urine before the onset of illness in our hamster model of leptospirosis. This is the first study reporting that leptospiral HADH is released in the urine during the infection. Therefore, this protein could be applicable in early diagnostic assays for human leptospirosis.
Leptospira interrogans serovar Manilae strain K64 that was isolated from the kidneys of a rat in the Philippines  was used in this study, and cultured in modified Korthof’s medium supplemented with 10% rabbit serum at 30°C. Prior to experiments, strain K64 was passaged through hamsters to maintain its virulence. Strain K64 passaged less than ten times in vitro was used for experiments. LD50 of strain K64 was determined by infecting hamsters with serially diluted leptospiral suspension [56, 57]. As a result, the LD50 of K64 strain was 100.
Male golden Syrian hamsters (Japan SLC, Inc., Shizuoka, Japan), 4 weeks of age, were injected subcutaneously with 103 low-passaged (less than 10× in vitro) leptospires at a final volume of 1 ml Korthof’s medium. As negative controls, animals were injected with Korthof’s medium only. The urine of infected animals was collected by housing them in metabolic chambers for 6 hours daily until they were moribund. Hamster kidneys, livers, spleens, lungs and brains were collected aseptically and squeezed into modified Korthof’s medium containing 5-FU using 5 ml syringe, and incubated at 30°C . Five hundred microliters of culture supernatant was sub-cultured into fresh medium without 5-FU the next day and was kept at 30°C and examined for growth of leptospires daily for one month. Moribund hamsters and those that survived infection after 9 days were sacrificed through inhalation with sevoflurane (Maruishi Pharmaceutical, Japan).
All animal experiments were reviewed and approved by the Ethics Committee on Animal Experiment at the Faculty of Medical Sciences, Kyushu University. The experiments were carried out following the Regulations for Animal Experiments of Kyushu University and The Law (No. 105) and Notification (No. 6) of the Government of Japan.
The pH of hamster urine was tested using pH test paper BTB (07010060, Advantec, Tokyo, Japan). Glucose, bilirubin, ketone, specific gravity, blood, protein, urobilinogen, nitrite, and leukocyte were measured with N-MULTISTIX® SG-L (Siemens Healthcare Diagnostics Inc., NY). The turbidity of hamster urine was measured using Wallac ARVO sx 1420 multilabel counter (Perkin Elmer, Waltham, MA, USA) at a wavelength of 600 nm.
Pre-treatment of urine for gel electrophoresis
Due to the small amount of urine collected, urine from three infected hamsters was pooled and used in the experiments. For proteomic analysis, urine samples were first centrifuged at 1500 × g for 10 min at 4°C to remove debris. The supernatants were concentrated and desalted to remove interfering substances by centrifugation at 7500 × g for 30 min at 4°C using a centrifugal filter device (Amicon Ultra 4 molecular mass cutoff, 10-kDa; Merck Millipore, Billerica, MA, USA) as previously described . The desalted concentrates were stored at −20°C until further use. Protein concentration in urine was determined using 2-D Quant Kit (GE Healthcare UK Ltd, Little Chalfont, UK) and processed for gel electrophoresis.
Sodium dodecyl sulfide–polyacrylamide gel electrophoresis (SDS-PAGE)
For SDS-PAGE, the concentrated and desalted urine samples were dissolved in Laemmli sample buffer (Bio-Rad Laboratories, BioRad, Hercules, CA, USA) with 5% beta-mercaptoethanol and incubated at 94°C for 5 min. SDS-PAGE was performed with 10% acrylamide gels. Electrophoresis was performed using a Mini-PROTEAN tetra cell (Bio-Rad Laboratories, BioRad, Hercules, CA, USA) for 120 min at 20 mA in Tris-glycine running buffer (25 mM Tris, 192 mM glycine, 0.1% sodium dodecyl sulfate). Separated proteins were stained using Silver Stain MS Kit (WAKO, Osaka, Japan).
Two dimensional electrophoresis (2-DE)
2-DE of the urine samples was analyzed using the Multiphor II Electrophoresis system (GE Healthcare UK Ltd, Little Chalfont, UK) according to the manufacturer’s instructions with some modifications. Briefly, the desalted urine sample was dissolved and recovered with 400 μl of 8 M urea, 4% CHAPS and 50 mM Tris/HCl (pH 8.0). Ten mM DTT and 1% Pharmalyte, broad range pH 3–10 (GE Healthcare UK Ltd, Little Chalfont, UK) including range pH 4–7 were added as rehydration buffer prior to loading for the first dimension. Samples were directly added into the rehydration buffer and the 11 cm immobilized gradient strip (pH 4–7) was allowed to swell overnight at room temperature. The isoelectric focusing (IEF) conditions were as follows: (i) 1 min at a 300 V gradient, (ii) 1.5 h at a 3500 V gradient, (iii) 5 h at 3500 V, with a 50 μA per strip maximum at 15°C. The completed first-dimensional strip was subjected to 2-D SDS-PAGE with 12.5% acrylamide gel. Separated proteins were stained by silver staining as mentioned above.
Cloning and expression of recombinant HADH
A 1311-bp LIC13300 DNA fragment was amplified using oligomers LIC13300-F 5′-GGAATTCCATATGAGAGAAATCAAAACAGTAACAG-3′ and LIC13300-R 5′-CCGCTCGAGTCCTTTGAAAAGTGAACGAGC-3′ designed based on L. interrogans serovar Copenhageni genome sequences (GenBank accession YP_003205). PCR was performed with KOD plus ver. 2 PCR kit (Toyobo, Osaka, Japan) from strain K64. Cycling conditions were: 95°C, 5 min, followed by 40 cycles at 95°C, 1 min, 50°C, 1 min, 68°C, 2 min, and a final extension cycle of 5 min, 68°C. PCR product was digested with Nde I and Xho I (Roche, Basel, Schweiz), ligated to Nde I- and Xho I- digested expression vector, pET-28a (+) (Novagen, San Diego, CA). The ligated plasmid was amplified in E. coli DH5α and purified using Midi PlusTM Ultrapure Plasmid Extraction System (Viogene, Taipei, Taiwan). After confirming the presence of correct inserts by sequence analysis, the plasmid was transformed in E. coli (DE3). Cultures were grown to OD600 = 0.5 and protein expression was induced with 1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG), and incubated at 25°C overnight. His-tagged LIC13300 recombinant protein (rHADH) was purified under native conditions with TALON® Metal Affinity Resin (Clontech) as previously described .
Antiserum against rHADH
One female Japanese white rabbit (Biotek. Co.,Ltd., Japan) weighing 1.5 kg was immunized subcutaneously with 30 μg of the recombinant protein. The rHADH was mixed with an equal volume of complete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO) to make an emulsion. Four subsequent booster injections were given at two-week intervals in the same way, by using incomplete Freund’s adjuvant (Sigma-Aldrich, St. Louis, MO). One week after the final immunization, the blood of rabbit was collected through cardiac puncture and the serum was analyzed by immunoblotting.
Proteins separated by SDS-PAGE were transferred to an Immobilon-P transfer membrane (Merck Millipore, Billerica, MA, USA) and blocked with 1% (wt/vol) nonfat dry milk (WAKO, Osaka, Japan) in TBS-0.05% Tween 20 (TBS-T). The membranes were incubated overnight at 4°C with polyclonal antibody produced against live whole cells of L. interrogans serovar Manilae (anti-L. interrogans pAb) (1:1000 dilution)  or anti-HADH rabbit antiserum polyclonal antibody (1:5000), followed by incubation for 2 h at room temperature with horseradish peroxidase (HRP)-donkey anti-rabbit IgG conjugate (1:5000 dilution; GE Healthcare UK Ltd, Little Chalfont, UK), or with anti-His (C-term) mouse mAb (1:5000 dilution; Life technologies, Carlsbad, CA, USA), followed by incubation for 2 h at room temperature with horseradish peroxidase (HRP)-sheep anti-mouse IgG conjugate (1:10000 dilution; GE Healthcare UK Ltd, Little Chalfont, UK). The bands were detected with EzWest Lumi plus (ATTO, Tokyo, Japan) and ImageQuant LAS 4000mini (GE Healthcare UK Ltd, Little Chalfont, UK).
Liquid chromatography (LC)/mass spectrometry (MS) analysis
Protein spots in gels were compared and analyzed by visual inspection. The gel spots were stored in 1% acetic acid and were subjected to LC/MS/MS analysis. Identification of proteins was carried out using Mascot server (Matrix Science) with datasets of rodent and Leptospira proteomes. A protein score of >40 was used to select proteins with significant matching. The difference between the theoretical and experimental mass and pI was also used to determine significant matching.
Coomassie brilliant blue
Enzyme-linked immunosorbent assay
Japan International Cooperation Agency
Japan Science and Technology Agency
Microscopic agglutination test
- anti-L. interrogans pAb:
Polyclonal antibody produced against live whole cells of L. interrogans serovar Manilae
Polymerase chain reaction
Science and Technology Research Partnership for Sustainable Development
Sodium dodecyl sulfide–polyacrylamide gel electrophoresis
TBS-0.05% Tween 20
Two dimensional electrophoresis.
This study was supported by a grant of the Science and Technology Research Partnership for Sustainable Development (SATREPS) program from Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA). We thank Dr. H. Sumimoto and colleagues of the Research Support Center, Graduate School of Medical Sciences, Kyushu University for their technical support and advice. We also thank Sayaka Akiyoshi, Takayoshi Yamaguchi, Hideko Kameyama, and Naomi Hidaka for their technical cooperation.
- Levett PN: Leptospirosis. Clin Microbiol Rev. 2001, 14 (2): 296-326. 10.1128/CMR.14.2.296-326.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, Peru-United States Leptospirosis Consortium: Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003, 3 (12): 757-771. 10.1016/S1473-3099(03)00830-2.View ArticlePubMedGoogle Scholar
- Picardeau M: Diagnosis and epidemiology of leptospirosis. Med Mal Infect. 2013, 43 (1): 1-9. 10.1016/j.medmal.2012.11.005.View ArticlePubMedGoogle Scholar
- Adler B, de la Pena MA: Leptospira and leptospirosis. Vet Microbiol. 2010, 140 (3–4): 287-296.View ArticlePubMedGoogle Scholar
- Toyokawa T, Ohnishi M, Koizumi N: Diagnosis of acute leptospirosis. Expert Rev Anti Infect Ther. 2011, 9 (1): 111-121. 10.1586/eri.10.151.View ArticlePubMedGoogle Scholar
- Vijayachari P, Sugunan AP, Shriram AN: Leptospirosis: an emerging global public health problem. J Biosci. 2008, 33 (4): 557-569. 10.1007/s12038-008-0074-z.View ArticlePubMedGoogle Scholar
- Camargo ED, da Silva MV, Batista L, Vaz AJ, Sakata EE: An evaluation of the ELISA-IgM test in the early diagnosis of human leptospirosis. Rev Inst Med Trop Sao Paulo. 1992, 34 (4): 355-357.View ArticlePubMedGoogle Scholar
- Fonseca Cde A, Teixeira MM, Romero EC, Tengan FM, Silva MV, Shikanai-Yasuda MA: Leptospira DNA detection for the diagnosis of human leptospirosis. J Infect. 2006, 52 (1): 15-22. 10.1016/j.jinf.2005.02.022.View ArticlePubMedGoogle Scholar
- Balassiano IT, Vital-Brazil JM, Pereira MM: Leptospirosis diagnosis by immunocapture polymerase chain reaction: a new tool for early diagnosis and epidemiologic surveillance. Diagn Microbiol Infect Dis. 2012, 74 (1): 11-15. 10.1016/j.diagmicrobio.2012.05.028.View ArticlePubMedGoogle Scholar
- Koizumi N, Watanabe H, Umezawa K, Iiduka T, Inokuchi S: A case of leptospirosis diagnosed early by flaB-PCR. Kansenshogaku Zasshi. 2003, 77 (8): 627-630.View ArticlePubMedGoogle Scholar
- Brown PD, Gravekamp C, Carrington DG, van de Kemp H, Hartskeerl RA, Edwards CN, Everard CO, Terpstra WJ, Levett PN: Evaluation of the polymerase chain reaction for early diagnosis of leptospirosis. J Med Microbiol. 1995, 43 (2): 110-114. 10.1099/00222615-43-2-110.View ArticlePubMedGoogle Scholar
- Goris MG, Leeflang MM, Loden M, Wagenaar JF, Klatser PR, Hartskeerl RA, Boer KR: Prospective evaluation of three rapid diagnostic tests for diagnosis of human leptospirosis. PLoS Negl Trop Dis. 2013, 7 (7): e2290-10.1371/journal.pntd.0002290.PubMed CentralView ArticlePubMedGoogle Scholar
- Ooteman MC, Vago AR, Koury MC: Evaluation of MAT, IgM ELISA and PCR methods for the diagnosis of human leptospirosis. J Microbiol Methods. 2006, 65 (2): 247-257. 10.1016/j.mimet.2005.07.015.View ArticlePubMedGoogle Scholar
- McBride AJ, Santos BL, Queiroz A, Santos AC, Hartskeerl RA, Reis MG, Ko AI: Evaluation of four whole-cell Leptospira-based serological tests for diagnosis of urban leptospirosis. Clin Vaccine Immunol. 2007, 14 (9): 1245-1248. 10.1128/CVI.00217-07.PubMed CentralView ArticlePubMedGoogle Scholar
- Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, Plikaytis BD, Perkins BA, Phelan M, Levett PN, Weyant RS: Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003, 41 (2): 803-809. 10.1128/JCM.41.2.803-809.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Eapen CK, Sugathan S, Kuriakose M, Abdoel T, Smits HL: Evaluation of the clinical utility of a rapid blood test for human leptospirosis. Diagn Microbiol Infect Dis. 2002, 42 (4): 221-225. 10.1016/S0732-8893(01)00361-3.View ArticlePubMedGoogle Scholar
- Signorini ML, Lottersberger J, Tarabla HD, Vanasco NB: Enzyme-linked immunosorbent assay to diagnose human leptospirosis: a meta-analysis of the published literature. Epidemiol Infect. 2013, 141 (1): 22-32. 10.1017/S0950268812001951.View ArticlePubMedGoogle Scholar
- Musso D, La Scola B: Laboratory diagnosis of leptospirosis: a challenge. J Microbiol Immunol Infect. 2013, 46 (4): 245-252. 10.1016/j.jmii.2013.03.001.View ArticlePubMedGoogle Scholar
- Widiyanti D, Koizumi N, Fukui T, Muslich LT, Segawa T, Villanueva SY, Saito M, Masuzawa T, Gloriani NG, Yoshida S: Development of immunochromatography-based methods for detection of leptospiral lipopolysaccharide antigen in urine. Clin Vaccine Immunol. 2013, 20 (5): 683-690. 10.1128/CVI.00756-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Saengjaruk P, Chaicumpa W, Watt G, Bunyaraksyotin G, Wuthiekanun V, Tapchaisri P, Sittinont C, Panaphut T, Tomanakan K, Sakolvaree Y, Chongsa-Nguan M, Mahakunkijcharoen Y, Kalambaheti T, Naigowit P, Wambangco MA, Kurazono H, Hayashi H: Diagnosis of human leptospirosis by monoclonal antibody-based antigen detection in urine. J Clin Microbiol. 2002, 40 (2): 480-489. 10.1128/JCM.40.3.480-489.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Ruiz VM, Vega LE, Velazquez RM: Use of polymerase chain reaction for the identification of Leptospira sp. in urine of carriers. Rev Cubana Med Trop. 2005, 57 (1): 47-48.PubMedGoogle Scholar
- Koizumi N, Nakajima C, Harunari T, Tanikawa T, Tokiwa T, Uchimura E, Furuya T, Mingala CN, Villanueva MA, Ohnishi M, Suzuki Y: A new loop-mediated isothermal amplification method for rapid, simple, and sensitive detection of Leptospira spp. in urine. J Clin Microbiol. 2012, 50 (6): 2072-2074. 10.1128/JCM.00481-12.PubMed CentralView ArticlePubMedGoogle Scholar
- Bomfim MR, Barbosa-Stancioli EF, Koury MC: Detection of pathogenic leptospires in urine from naturally infected cattle by nested PCR. Vet J. 2008, 178 (2): 251-256. 10.1016/j.tvjl.2007.07.029.View ArticlePubMedGoogle Scholar
- Suwimonteerabutr J, Chaicumpa W, Saengjaruk P, Tapchaisri P, Chongsa-nguan M, Kalambaheti T, Ramasoota P, Sakolvaree Y, Virakul P: Evaluation of a monoclonal antibody-based dot-blot ELISA for detection of Leptospira spp in bovine urine samples. Am J Vet Res. 2005, 66 (5): 762-766. 10.2460/ajvr.2005.66.762.View ArticlePubMedGoogle Scholar
- Bal AE, Gravekamp C, Hartskeerl RA, De Meza-Brewster J, Korver H, Terpstra WJ: Detection of leptospires in urine by PCR for early diagnosis of leptospirosis. J Clin Microbiol. 1994, 32 (8): 1894-1898.PubMed CentralPubMedGoogle Scholar
- Bolin CA, Zuerner RL, Trueba G: Comparison of three techniques to detect Leptospira interrogans serovar Hardjo type hardjo-bovis in bovine urine. Am J Vet Res. 1989, 50 (7): 1001-1003.PubMedGoogle Scholar
- Rai AJ: The urinary proteome. 2010, 641: 361-https://library.plantandfood.co.nz/cgi-bin/koha/opac-detail.pl?biblionumber=18633,View ArticleGoogle Scholar
- Haake DA: Hamster model of leptospirosis. Curr Protoc Microbiol. 2006, Chapter 12 (Unit 12E): 2-PubMedGoogle Scholar
- Sigdel TK, Kaushal A, Gritsenko M, Norbeck AD, Qian WJ, Xiao W, Camp DG, Smith RD, Sarwal MM: Shotgun proteomics identifies proteins specific for acute renal transplant rejection. Proteomics Clin Appl. 2010, 4 (1): 32-47. 10.1002/prca.200900124.PubMed CentralView ArticlePubMedGoogle Scholar
- Loftheim H, Midtvedt K, Hartmann A, Reisaeter AV, Falck P, Holdaas H, Jenssen T, Reubsaet L, Asberg A: Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients. Transplant Res. 2012, 1 (1): 9-10.1186/2047-1440-1-9.http://www.transplantationresearch.com/content/1/1/9,PubMed CentralView ArticlePubMedGoogle Scholar
- Burtis CA, Ashwood ER, Tietz NW: Tietz Textbook of Clinical Chemistry. 1999, Philadelphia: W.B. Saunders, 3Google Scholar
- Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS, Arthur JM: Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007, 18 (3): 913-922. 10.1681/ASN.2006070767.PubMed CentralView ArticlePubMedGoogle Scholar
- Riaz S, Skinner V, Srai SK: Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2. J Pharm Biomed Anal. 2011, 54 (4): 817-825. 10.1016/j.jpba.2010.11.008.View ArticlePubMedGoogle Scholar
- Burns KD, Hiremath S: Urinary angiotensinogen as a biomarker of chronic kidney disease: ready for prime time?. Nephrol Dial Transplant. 2012, 27 (8): 3010-3013. 10.1093/ndt/gfs166.View ArticlePubMedGoogle Scholar
- Penders J, Delanghe JR: Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta. 2004, 346 (2): 107-118. 10.1016/j.cccn.2004.03.037.View ArticlePubMedGoogle Scholar
- Short CD, Durrington PN, Mallick NP, Hunt LP, Tetlow L, Ishola M: Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int. 1986, 29 (6): 1224-1228. 10.1038/ki.1986.131.View ArticlePubMedGoogle Scholar
- Pesic I, Stefanovic V, Muller GA, Muller CA, Cukuranovic R, Jahn O, Bojanic V, Koziolek M, Dihazi H: Identification and validation of six proteins as marker for endemic nephropathy. J Proteomics. 2011, 74 (10): 1994-2007. 10.1016/j.jprot.2011.05.020.View ArticlePubMedGoogle Scholar
- Lessa-Aquino C, Borges Rodrigues C, Pablo J, Sasaki R, Jasinskas A, Liang L, Wunder EA, Ribeiro GS, Vigil A, Galler R, Molina D, Liang X, Reis MG, Ko AI, Medeiros MA, Felgner PL: Identification of seroreactive proteins of Leptospira interrogans serovar Copenhageni using a high-density protein microarray approach. PLoS Negl Trop Dis. 2013, 7 (10): e2499-10.1371/journal.pntd.0002499.PubMed CentralView ArticlePubMedGoogle Scholar
- Raja V, Natarajaseenivasan K: Pathogenic, diagnostic and vaccine potential of leptospiral outer membrane proteins (OMPs). Crit Rev Microbiol. 2013,http://informahealthcare.com/doi/abs/10.3109/1040841X.2013.787387,Google Scholar
- Pretre G, Lapponi MJ, Atzingen MV, Schattner M, Nascimento AL, Gomez RM: Characterization of LIC11207, a novel leptospiral protein that is recognized by human convalescent sera and prevents apoptosis of polymorphonuclear leukocytes. Microb Pathog. 2013, 56: 21-28.View ArticlePubMedGoogle Scholar
- Subathra M, Senthilkumar TM, Ramadass P: Recombinant OmpL1 protein as a diagnostic antigen for the detection of canine leptospirosis. Appl Biochem Biotechnol. 2013, 169 (2): 431-437. 10.1007/s12010-012-9973-4.View ArticlePubMedGoogle Scholar
- Natarajaseenivasan K, Vijayachari P, Sharma S, Sugunan AP, Selvin J, Sehgal SC: Serodiagnosis of severe leptospirosis: evaluation of ELISA based on the recombinant OmpL1 or LipL41 antigens of Leptospira interrogans serovar Autumnalis. Ann Trop Med Parasitol. 2008, 102 (8): 699-708. 10.1179/136485908X355229.View ArticlePubMedGoogle Scholar
- Oliveira TR, Longhi MT, de Morais ZM, Romero EC, Blanco RM, Kirchgatter K, Vasconcellos SA, Nascimento AL: Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clin Vaccine Immunol. 2008, 15 (11): 1715-1722. 10.1128/CVI.00214-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Sridhar V, Manjulata Devi S, Ahmed N, Sritharan M: Diagnostic potential of an iron-regulated hemin-binding protein HbpA that is widely conserved in Leptospira interrogans. Infect Genet Evol. 2008, 8 (6): 772-776. 10.1016/j.meegid.2008.07.004.View ArticlePubMedGoogle Scholar
- Srimanote P, Wongdeethai N, Jieanampunkul P, Samonkiert S, Leepiyasakulchai C, Kalambaheti T, Prachayasittikul V: Recombinant LigA for leptospirosis diagnosis and LigA among the Leptospira spp. clinical isolates. J Microbiol Methods. 2008, 72 (1): 73-81. 10.1016/j.mimet.2007.10.012.View ArticlePubMedGoogle Scholar
- Neves FO, Abreu PA, Vasconcellos SA, de Morais ZM, Romero EC, Nascimento AL: Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Arch Microbiol. 2007, 188 (5): 523-532. 10.1007/s00203-007-0273-2.View ArticlePubMedGoogle Scholar
- Coutinho ML, Vasconcellos FA, Fernandes CP, Seyffert N, Seixas FK, Ko AI, Dellagostin OA, Aleixo JA: Evaluation of the anti-LipL32 monoclonal antibodies potential for use in leptospirosis immunodiagnostic tests. J Immunoassay Immunochem. 2007, 28 (3): 279-288. 10.1080/15321810701454870.View ArticlePubMedGoogle Scholar
- Humphryes PC, Weeks ME, Gielbert A, Thomson G, Coldham NG: Analysis of multiple Leptospira interrogans serovar Canicola vaccine proteomes and identification of LipL32 as a biomarker for potency. Clin Vaccine Immunol. 2012, 19 (4): 587-593. 10.1128/CVI.05622-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Kucerova P, Cermakova Z, Pliskova L, Pavlis O, Kubickova P, Kleprlikova H, Valenta Z: Our experience using real-time PCR for the detection of the gene that encodes the superficial lipoprotein LipL32 of the pathogenic leptospires to confirm the acute form of human leptospirosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013, 157 (4): 387-391.PubMedGoogle Scholar
- Cheemaa PS, Srivastava SK, Amutha R, Singh S, Singh H, Sandey M: Detection of pathogenic leptospires in animals by PCR based on lipL21 and lipL32 genes. Indian J Exp Biol. 2007, 45 (6): 568-573.PubMedGoogle Scholar
- Joseph S, Thomas N, Thangapandian E, Singh VP, Verma R, Srivastava SK: Evaluation and comparison of native and recombinant LipL21 protein-based ELISAs for diagnosis of bovine leptospirosis. J Vet Sci. 2012, 13 (1): 99-101. 10.4142/jvs.2012.13.1.99.PubMed CentralView ArticlePubMedGoogle Scholar
- Bughio NI, Lin M, Surujballi OP: Use of recombinant flagellin protein as a tracer antigen in a fluorescence polarization assay for diagnosis of leptospirosis. Clin Diagn Lab Immunol. 1999, 6 (4): 599-605.PubMed CentralPubMedGoogle Scholar
- Monahan AM, Callanan JJ, Nally JE: Proteomic analysis of Leptospira interrogans shed in urine of chronically infected hosts. Infect Immun. 2008, 76 (11): 4952-4958. 10.1128/IAI.00511-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Nally JE, Monahan AM, Miller IS, Bonilla-Santiago R, Souda P, Whitelegge JP: Comparative proteomic analysis of differentially expressed proteins in the urine of reservoir hosts of leptospirosis. PLoS One. 2011, 6 (10): e26046-10.1371/journal.pone.0026046.PubMed CentralView ArticlePubMedGoogle Scholar
- Syrian Hamsters: biology: urine.http://ehs.uc.edu/lams/data/hamsters/9028/28_031.html,
- Villanueva SY, Ezoe H, Baterna RA, Yanagihara Y, Muto M, Koizumi N, Fukui T, Okamoto Y, Masuzawa T, Cavinta LL, Gloriani NG, Yoshida S: Serologic and molecular studies of Leptospira and leptospirosis among rats in the Philippines. Am J Trop Med Hyg. 2010, 82 (5): 889-898. 10.4269/ajtmh.2010.09-0711.PubMed CentralView ArticlePubMedGoogle Scholar
- Villanueva SY, Saito M, Tsutsumi Y, Segawa T, Baterna RA, Chakraborty A, Asoh T, Miyahara S, Yanagihara Y, Cavinta LL, Gloriani NG, Yoshida SI: High virulence in hamsters of four dominantly prevailing Leptospira serovars isolated from rats in the Philippines. Microbiology. 2014, 160 (Pt 2): 418-428.View ArticlePubMedGoogle Scholar
- Yokota H, Hiramoto M, Okada H, Kanno Y, Yuri M, Morita S, Naitou M, Ichikawa A, Katoh M, Suzuki H: Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria. Mol Cell Proteomics. 2007, 6 (4): 738-744. 10.1074/mcp.M600336-MCP200.View ArticlePubMedGoogle Scholar
- Yoshimura S, Haas AK, Barr FA: Analysis of Rab GTPase and GTPase-activating protein function at primary cilia. Methods Enzymol. 2008, 439: 353-364.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.